These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16104060)

  • 1. Two-dimensional liquid chromatography/tandem mass spectrometry analysis of Gradiflow fractionated native human plasma.
    Wasinger VC; Locke VL; Raftery MJ; Larance M; Rothemund D; Liew A; Bate I; Guilhaus M
    Proteomics; 2005 Aug; 5(13):3397-401. PubMed ID: 16104060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map.
    Cho SY; Lee EY; Lee JS; Kim HY; Park JM; Kwon MS; Park YK; Lee HJ; Kang MJ; Kim JY; Yoo JS; Park SJ; Cho JW; Kim HS; Paik YK
    Proteomics; 2005 Aug; 5(13):3386-96. PubMed ID: 16047310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
    Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
    Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.
    Omenn GS; States DJ; Adamski M; Blackwell TW; Menon R; Hermjakob H; Apweiler R; Haab BB; Simpson RJ; Eddes JS; Kapp EA; Moritz RL; Chan DW; Rai AJ; Admon A; Aebersold R; Eng J; Hancock WS; Hefta SA; Meyer H; Paik YK; Yoo JS; Ping P; Pounds J; Adkins J; Qian X; Wang R; Wasinger V; Wu CY; Zhao X; Zeng R; Archakov A; Tsugita A; Beer I; Pandey A; Pisano M; Andrews P; Tammen H; Speicher DW; Hanash SM
    Proteomics; 2005 Aug; 5(13):3226-45. PubMed ID: 16104056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
    Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P
    Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of electrophoretically derived protein mass estimates as additional constraints in proteome analysis of human serum based on MS/MS analysis.
    Kim JY; Lee JH; Park GW; Cho K; Kwon KH; Park YM; Cho SY; Paik YK; Yoo JS
    Proteomics; 2005 Aug; 5(13):3376-85. PubMed ID: 16052618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes.
    Faca V; Pitteri SJ; Newcomb L; Glukhova V; Phanstiel D; Krasnoselsky A; Zhang Q; Struthers J; Wang H; Eng J; Fitzgibbon M; McIntosh M; Hanash S
    J Proteome Res; 2007 Sep; 6(9):3558-65. PubMed ID: 17696519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
    Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
    J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of 2-D free-flow electrophoresis/RP-HPLC for proteomic analysis of human plasma depleted of multi high-abundance proteins.
    Moritz RL; Clippingdale AB; Kapp EA; Eddes JS; Ji H; Gilbert S; Connolly LM; Simpson RJ
    Proteomics; 2005 Aug; 5(13):3402-13. PubMed ID: 16052629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data.
    Haab BB; Geierstanger BH; Michailidis G; Vitzthum F; Forrester S; Okon R; Saviranta P; Brinker A; Sorette M; Perlee L; Suresh S; Drwal G; Adkins JN; Omenn GS
    Proteomics; 2005 Aug; 5(13):3278-91. PubMed ID: 16038022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis.
    Govorukhina NI; Reijmers TH; Nyangoma SO; van der Zee AG; Jansen RC; Bischoff R
    J Chromatogr A; 2006 Jul; 1120(1-2):142-50. PubMed ID: 16574134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of immunoaffinity depletion of human serum during proteomic investigations.
    Yocum AK; Yu K; Oe T; Blair IA
    J Proteome Res; 2005; 4(5):1722-31. PubMed ID: 16212426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
    Turtoi A; Mazzucchelli GD; De Pauw E
    Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes.
    Tang HY; Ali-Khan N; Echan LA; Levenkova N; Rux JJ; Speicher DW
    Proteomics; 2005 Aug; 5(13):3329-42. PubMed ID: 16052622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-dimensional separation of human plasma proteins using iterative free-flow electrophoresis.
    Nissum M; Kuhfuss S; Hauptmann M; Obermaier C; Sukop U; Wildgruber R; Weber G; Eckerskorn C; Malmström J
    Proteomics; 2007 Dec; 7(23):4218-27. PubMed ID: 17973290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum.
    Zolotarjova N; Mrozinski P; Chen H; Martosella J
    J Chromatogr A; 2008 May; 1189(1-2):332-8. PubMed ID: 18154976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different immunoaffinity fractionation strategies to characterize the human plasma proteome.
    Gong Y; Li X; Yang B; Ying W; Li D; Zhang Y; Dai S; Cai Y; Wang J; He F; Qian X
    J Proteome Res; 2006 Jun; 5(6):1379-87. PubMed ID: 16739989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system.
    Misek DE; Kuick R; Wang H; Galchev V; Deng B; Zhao R; Tra J; Pisano MR; Amunugama R; Allen D; Walker AK; Strahler JR; Andrews P; Omenn GS; Hanash SM
    Proteomics; 2005 Aug; 5(13):3343-52. PubMed ID: 16047307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human serum proteins fractionated by preparative partition chromatography prior to LC-ESI-MS/MS.
    Tucholska M; Bowden P; Jacks K; Zhu P; Furesz S; Dumbrovsky M; Marshall J
    J Proteome Res; 2009 Mar; 8(3):1143-55. PubMed ID: 19265436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.